Pamela Morin

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: a real-world analysis of health plan enrollees”.

Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: a real-world analysis of health plan enrollees

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1855340

N/A

0DataRank · unranked

20 citations

David R. Doody, Jennifer J. Wilkes, Laura Becker, Shasank Chennupati, Pamela Morin +4 more

Health Care Cost Associated With Contemporary Chronic Myelogenous Leukemia Therapy Compared With That of Other Hematologic Malignancies

JCO Oncology Practice(2020)10.1200/op.20.00143

N/A

0DataRank · unranked

12 citations

Gary H. Lyman, David R. Doody, Shasank Chennupati, Laura Becker, Pamela Morin +4 more